Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
6.10
-0.32 (-4.98%)
At close: Aug 13, 2025, 4:00 PM
6.22
+0.12 (1.97%)
After-hours: Aug 13, 2025, 6:56 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
T Cell Redirecting Immunotherapies
58.38M
Log In
Log In
Log In
Log In
Upgrade
T Cell Redirecting Immunotherapies Growth
-67.86%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Germany
58.38M
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-67.86%
Log In
Log In
Log In
Log In
Upgrade